Berli Jucker Public Company (BJC) Fair Value & Analysis
Industrials · TH · Market cap 55.7B THB
Analysis
Berli Jucker Public Company (BJC) currently trades at 14.00 THB, while our model-based Fair Value estimate is 17.01 THB — implying the stock looks roughly 21.5% undervalued today. We read business quality at 92/100 (high quality), in the Industrials sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: high) — always confirm before acting.
About the company
Berli Jucker Public Company Limited manufactures, distributes, and services for packaging, consumer, healthcare and technical, and modern retail supply chain businesses in Thailand. It designs, manufactures, markets, and distributes glass, aluminum cans, and plastic packaging products. The company also provides Cellox facial tissues and toilet paper, Zilk toilet papers, Maxmo multi-purpose papers, Tasto potato chips, Dozo rice crackers, Party and Campus extruded snacks, Parrot soaps, and Dermapon baby soaps; and logistics services. It distributes pharmaceutical and healthcare products, medical imaging, and medical equipment and supplies; solutions for graphic, stationery, and specialty products; and industrial chemical ingredients, engineering products and systems, galvanized steel structures, and digital printing technology. The company also operates network of multiple physical and online store; and wholesale business serving B2B customer, bookstore, coffee shop, and drug store bu…
Open the full interactive analysis →
Similar stocks
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.